IP Library Granted Patent US 11,344,473
Granted Patent B2
US 11,344,473 · App. 16/121,046 · Granted May 31, 2022

Coated packaging

Inventors: Christopher Weikart (Auburn, AL); Becky L. Clark (Auburn, AL); Adam Stevenson (Opelika, AL); John T. Felts (Alameda, CA)
Assignee: SiO2Medical Products, Inc.
A61J1/1468A61J1/00A61J1/035A61J1/05A61L31/04A61L31/08A61L31/088A61L31/143A61L31/16A61M5/3129B65D25/14C23C16/029C23C16/045C23C16/401C23C16/45523C23C16/50A61L2420/02A61L2420/08A61M2005/3131A61M2205/0238
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,344,473
App. No.
16/121,046
Granted
May 31, 2022
Kind
B2
Abstract

A vessel has an interior surface facing a lumen. The interior surface includes a tie coating or layer, a barrier coating or layer, and a pH protective coating or layer. The tie coating or layer can comprise SiO x C y or SiN x C y , where x is from about 0.5 to about 2.4 and y is from about 0.6 to about 3. The barrier coating or layer can comprise SiO x , wherein x is from 1.5 to 2.9. The barrier coating or layer reduces the ingress of atmospheric gas into the lumen. The pH protective coating or layer can comprise SiO x C y or SiN x C y , as well. In an embodiment, in the presence of a fluid composition contained in the lumen and having a pH between 5 and 9, the calculated shelf life of the package can be more than six months at a storage temperature of 4° C.

Claims (84)

1. A vessel comprising:

a thermoplastic wall having an interior surface enclosing at least a portion of a lumen;

a tie coating or layer comprising SiO x C y H z or SiN x C y H z in which x is from 0.5 to 2.4 as measured by X-ray photoelectron spectroscopy (XPS), y is from 0.6 to 3 as measured by XPS, and z is from 2 to 9 as measured by Rutherford backscattering spectrometry (RBS), the tie coating or layer having an outer surface facing the interior surface of the thermoplastic wall and the tie coating or layer having an interior surface;

a barrier coating or layer of SiO x , in which x is from 1.5 to 2.9 as measured by XPS, the barrier coating or layer positioned between the interior surface of the tie coating or layer and the lumen; and

a pH protective coating or layer of SiO x C y H z , in which x is from 0.5 to 2.4 as measured by XPS, y is from 0.6 to 3 as measured by XPS, and z is from 2 to 9 as measured by RBS, positioned between the barrier coating or layer and the lumen, in which an FTIR absorbance spectrum of the pH protective coating or layer has a ratio greater than 0.9 between:

the maximum amplitude of the Si-O-Si symmetrical stretch peak between 1000 and 1040 cm −1 , and

the maximum amplitude of the Si-O-Si asymmetric stretch peak between 1060 and 1100 cm −1 ;

in which the silicon dissolution rate by a 50 mM potassium phosphate buffer diluted in water for injection, adjusted to pH 8 with concentrated nitric acid, and containing 0.2 wt. % polysorbate-80 surfactant, from the vessel is less than 170 ppb/day.

2. The vessel of claim 1 , in which at least one of the tie coating or layer, the barrier coating or layer, or the pH protective coating or layer is applied by plasma enhanced chemical vapor deposition (PECVD).

3. The vessel of claim 1 , which is a syringe barrel, a vial, a cartridge or a blister package.

4. The vessel of claim 1 , in which at least a portion of the thermoplastic wall comprises:

a polyolefin

a polyvinylalcohol

a polymethacrylate ether

a polyacrylic acid

a polyamide

a polyimide

a polysulfone

a polylactic acid

a cyclic olefin polymer or copolymer

a polyester or

a combination of a polyolefin and a polyester.

5. The vessel of claim 1 , in which, for at least one of the pH protective coating or layer or the tie coating or layer, x is from 1 to 2 as measured by XPS, y is from 0.6 to 1.5 as measured by XPS, and z is from 2 to 5 as measured by RBS.

6. The vessel of claim 1 , in which the pH protective coating or layer is from 10 to 1000 nm thick.

7. The vessel of claim 1 , in which the rate of erosion of the pH protective coating or layer, if directly contacted by a fluid contained in the lumen having a pH greater than 5, is less than 20% of the rate of erosion of the barrier coating or layer, if directly contacted by the same fluid under the same conditions.

8. The vessel of claim 1 , having a shelf life, while directly contacted by a fluid contained in the lumen having a pH greater than 5, of at least two years, based on storage of the vessel containing the fluid at 20° C.

9. The vessel of claim 1 , in which a fluid contained in the lumen having a pH greater than 5 removes the pH protective coating or layer at a rate of 1 nm or less of pH protective coating or layer thickness per 88 hours of contact with the fluid.

10. The vessel of claim 1 , wherein the pH protective coating or layer shows an O-Parameter measured with attenuated total reflection (ATR) of less than 0.4, measured as:

O

-

Parameter

=

Intensity

at

1253

cm

-

1

Maximum

intensity

in

the

range

from

1000

to

1100

cm

-

1

.

11. The vessel of claim 1 , in which the tie coating or layer has an average thickness from 5 to 200 nm.

12. The vessel of claim 1 , which is a prefilled syringe having a syringe barrel coated on its interior wall with the tie coating or layer, barrier coating or layer, and pH protective coating or layer, further having a plunger seated in the barrel and containing a pharmaceutical composition having a pH greater than 5 contained in the lumen, the prefilled syringe having a shelf life of at least six months.

13. A process for making a vessel according to claim 1 , the process comprising the steps:

forming a tie coating or layer;

forming a barrier coating or layer; and

forming a pH protective coating or layer positioned between the barrier coating or layer and the lumen,

the pH protective coating or layer and tie coating or layer together being effective to keep the barrier coating or layer at least substantially undissolved as a result of attack by a fluid contained in the lumen having a pH greater than 5 for a period of at least six months.

Assignments (6)
SECURITY INTEREST Recorded Sep 5, 2024
From: SIO2 MEDICAL PRODUCTS, LLC
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 068849/0489 →
CHANGE OF NAME Recorded Sep 4, 2024
From: SIO2 MEDICAL PRODUCTS, INC.
To: SIO2 MEDICAL PRODUCTS, LLC
Reel/Frame 068839/0691 →
SECURITY INTEREST Recorded Aug 9, 2023
From: SIO2 MEDICAL PRODUCTS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 064544/0940 →
RELEASE OF SECURITY INTEREST Recorded Apr 5, 2023
From: THE TEACHERS RETIREMENT SYSTEM OF ALABAMA
To: SIO2 MEDICAL PRODUCTS, INC.
Reel/Frame 063257/0371 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2022
From: WEIKART, CHRISTOPHER; CLARK, BECKY L.; STEVENSON, ADAM; FELTS, JOHN T.
To: SIO2 MEDICAL PRODUCTS, INC.
Reel/Frame 059272/0238 →
SECURITY INTEREST Recorded Dec 21, 2021
From: SIO2 MEDICAL PRODUCTS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058562/0158 →
Cited By (1)
US 12,576,209